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Background: Postoperative recurrence at the surgical margins in 
the pulmonary parenchyma is one of type of local failure in patients 
undergoing limited surgery for lung cancer. To prevent this type of 
recurrence, we have introduced a novel technique of intraoperative 
lavage cytology of the surgical margins during limited surgery (JTCVS 
125:101,2003). This study examined the usefulness of this technique 
in contributing to the control of local recurrence in patients with small 
lung cancer.
Patients: Between 1973 and July 2005, limited surgery including seg-
mentectomy and wide wedge resection were preoperatively scheduled 
for a total 280 consecutive peripheral lung cancer lesions (20mm or 
less) in our institute. Of these, 95 lesions underwent surgery before 
clinical application of this cytologic technique in October 1997, and 
185 lesions were treated after the initiation of this procedure.
Results: In the ﬁrst 89 lesions, limited surgery was performed except in 
6 cases that underwent intraoperative conversion to completion lobec-
tomy due to nodal involvement. In contrast, among the latter cases, this 
technique detected positive cytological ﬁndings at the surgical margin 
in 7 lesions (3.8%). The surgical mode was immediately converted 
for 3 lesions (completion lobectomy in 2, additional resection in one). 
Completion lobectomy was performed due to nodal involvement in 7 
lesions and due to technical disadvantage in one. Therefore, limited 
surgery was ﬁnally performed for 175 lesions in the latter group. Dur-
ing a median postoperative follow-up period of 47.7 months, ranging 
from 10.1 to 180.4 months, local recurrence in the surgical margin of 
the pulmonary parenchyma was observed in 5 patients (5.6%) in the 
former group, but in only one (0.6%) of the latter. Interestingly, among 
the patients in whom cytologically negative margin was conﬁrmed by 
this intraoperative checking system, there has not been any local failure 
at the surgical margin to date.
Conclusions: Although this study was based on historical analysis, this 
intraoperative lavage cytologic technique is a promising tool to control 
local recurrence at the surgical margin following limited surgery for 
small lung cancer. In promoting limited surgery for small lung cancer, 
it is necessary to determine the presence of residual tumor cells using 
this novel technique for checking the surgical margin status. Cytologi-
cally negative results may be a promising indicator to prevent postop-
erative local failure.
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Background: Thoracic effusion is common in patients with advanced 
lung cancer which means impossible for curative surgery. Palliative 
VATS surgery is used in this situation. 
Method: We performed VATS pleura biopsy and Pleurodesis in 34 lung 
cancer patients with malignant thoracic effusion from 2003 to 2006. 
Result: There were 23 male and 11 female, age ranged from 45-84, 
adenocarcinoma 20 and squame carcinoma 4. Before operation we got 
pathological diagnosis by thoracentesis. In operation we evacuated the 
thoracic cavity and sprinkled 5g talcum powder all over the pleura sur-
face, then we eject 40mg cisplatin in thoracic cavity. We placed water 
sealed drainage after surgery for 3 to 14 days depending on amount of 
discharges from the drainage tube. After surgery all patients received 
standard chemotherapy and radiothreapy. There was no death associ-
ated with operation and no recurrence of thoracic effusion after surgery. 
Conclusions: VATS pleura biopsy can get more tissue than thoracen-
tesis to do immunohistochemistry, for example EGFR, ERCC1 and so 
on, which may provide us signiﬁcant imformation for futher treatment. 
Pleurodesis have a good effect on controlling thoracic effusion which 
can improve life quality for patients.
P3-227 NSCLC: Surgery Posters, Wed, Sept 5 – Thur, Sept 6 
Determinants of recurrence and survival in patients following 
surgery for stage IB non-small cell lung cancer
Hyun, Dae Sung; Park, Ki Sung; Kum, Yoon Seup 
Catholic University of Daegu, Daegu, Korea
Background: Early stage non-small cell lung cancer(NSCLC) is 
potentially curable by surgery, but long-term outcome after surgical 
resection is limited by disease recurrence locally or at sites distant from 
the primary disease. We conducted a retrospective study of NSCLC pa-
tients who underwent curative-intent surgery with stage IB(T2N0M0) 
to evaluate outcome variables. 
Methods: Forty-seven consecutive patients(35 male, 12 female) 
received curative-intent resection for stage IB NSCLC from January 
1998 to December 2005. Outcome variables analyzed included sex, 
types of operative procedure, histologic type and grade, tumor size, 
visceral pleural involvement. 
Results: The median age was 64 years(range from 39 to 77) and 
median follow up duration was 36 months. The operative procedures 
used were lobectomy in 40 patients and pneumonectomy in 7 patients. 
Twenty-ﬁve patients had histology of squamous cell and 22 patients 
had nonsquamous cell(including 14 adenocarcinomas). The overall 
5-year survival rate was 65.9%. The disease free survival(DFS) and 
overall survival(OS) rate were signiﬁcantly poor in patients with larger 
tumor(diameter >= 4 cm) compared with smaller tumor(diameter < 4 
cm) (p=0.01 and p=0.009, respectively). Patients with visceral pleural 
involvement had poor DFS rate compared with patients without vis-
ceral pleural involvement (p=0.03).
Conclusions: Tumor size was related to poor DFS and OS, and visceral 
pleural involvement was related to poor DFS in patients with stage IB 
NSCLC. Those patients may need to have adjuvant systemic therapy 
for improvement of outcome.
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